| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 151.57B | 150.74B | 136.16B | 129.36B | 127.82B | 117.25B |
| Gross Profit | 35.08B | 34.74B | 29.75B | 25.71B | 28.68B | 26.66B |
| EBITDA | 16.11B | 15.81B | 13.23B | 13.00B | 16.56B | 15.61B |
| Net Income | 6.56B | 6.53B | 4.53B | 4.85B | 7.69B | 7.28B |
Balance Sheet | ||||||
| Total Assets | 151.99B | 153.93B | 141.68B | 128.44B | 127.37B | 117.39B |
| Cash, Cash Equivalents and Short-Term Investments | 20.43B | 22.48B | 32.11B | 30.62B | 28.15B | 24.28B |
| Total Debt | 4.44B | 4.67B | 1.65B | 1.99B | 1.97B | 2.72B |
| Total Liabilities | 52.29B | 53.23B | 48.04B | 39.16B | 42.15B | 39.45B |
| Stockholders Equity | 91.29B | 92.00B | 85.96B | 82.45B | 79.34B | 73.06B |
Cash Flow | ||||||
| Free Cash Flow | -10.61B | -11.14B | 3.15B | 3.23B | 6.10B | 2.17B |
| Operating Cash Flow | 4.55B | 6.59B | 10.08B | 8.37B | 11.40B | 11.89B |
| Investing Cash Flow | -15.02B | -17.46B | -6.10B | -3.97B | -5.18B | -9.89B |
| Financing Cash Flow | 1.02B | 269.00M | -3.51B | -2.44B | -2.77B | -806.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥76.14B | 12.63 | ― | 6.64% | 2.85% | -9.13% | |
78 Outperform | ¥89.49B | 12.61 | 7.53% | 3.01% | 5.44% | 45.99% | |
77 Outperform | $174.93B | 10.96 | 10.46% | 2.35% | 4.56% | 49.23% | |
76 Outperform | ¥14.61B | 12.11 | ― | 1.20% | 6.42% | -6.32% | |
74 Outperform | ¥72.64B | 11.02 | ― | 3.31% | 0.83% | -9.16% | |
70 Outperform | ¥19.26B | 13.77 | ― | 4.39% | 5.06% | -15.22% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
ZACROS Corporation has reported the status of its ongoing share buyback program authorized by its board on November 6, 2025, under its Articles of Incorporation and the Companies Act of Japan. Between December 1 and December 31, 2025, the company repurchased 294,800 shares of its common stock on the Tokyo Stock Exchange for a total of ¥339.3 million, bringing cumulative buybacks under the current program to 538,500 shares at a cost of ¥604.0 million as of December 31, 2025. This activity is part of a broader authorization allowing repurchases of up to 1,820,000 shares, or 2.5% of outstanding shares excluding treasury stock, for a maximum of ¥2.0 billion through June 30, 2026, underscoring management’s active capital allocation policy and potential support for shareholder value.
The most recent analyst rating on (JP:7917) stock is a Buy with a Yen1248.00 price target. To see the full list of analyst forecasts on Fujimori Kogyo Co stock, see the JP:7917 Stock Forecast page.
ZACROS Corporation, a company listed on the Tokyo Stock Exchange, is implementing significant organizational changes to strengthen its business operational base and advance its 2030 Business Plan. These changes include the establishment of a new Life Solutions Business Unit, integrating the existing Wellness and Environmental Solutions Business Units, and the creation of a Quality Management Department to enhance quality and reliability. Additionally, several personnel changes have been announced, with new appointments effective December 1, 2025, aimed at bolstering the company’s strategic and operational capabilities.
The most recent analyst rating on (JP:7917) stock is a Buy with a Yen1248.00 price target. To see the full list of analyst forecasts on Fujimori Kogyo Co stock, see the JP:7917 Stock Forecast page.
ZACROS Corporation, a company listed on the Prime Market of the Tokyo Stock Exchange, has announced a strategic decision to repurchase up to 1,820,000 of its own shares, representing 2.5% of its total outstanding shares. This move, aimed at enhancing capital flexibility in response to evolving business conditions, involves a maximum expenditure of ¥2,000 million and will be executed through market purchases on the Tokyo Stock Exchange from November 7, 2025, to June 30, 2026.
The most recent analyst rating on (JP:7917) stock is a Buy with a Yen1248.00 price target. To see the full list of analyst forecasts on Fujimori Kogyo Co stock, see the JP:7917 Stock Forecast page.
ZACROS Corporation’s first-half financial results for fiscal year 2025 highlight their continued efforts in promoting health, environmental sustainability, and industrial infrastructure. The company aims to enhance its market position by providing innovative solutions across its diverse product segments, which could have significant implications for stakeholders and industry dynamics.
The most recent analyst rating on (JP:7917) stock is a Buy with a Yen1248.00 price target. To see the full list of analyst forecasts on Fujimori Kogyo Co stock, see the JP:7917 Stock Forecast page.
ZACROS Corporation has revised its earnings forecast for the fiscal year ending March 31, 2026, adjusting the profit attributable to owners of the parent from 7.5 billion yen to 6.5 billion yen due to a change in the timing of recognizing a special gain from a government subsidy. Additionally, the company has increased its interim and year-end dividend forecasts, reflecting its commitment to returning profits to shareholders, with a new full-year dividend per share set at 144 yen, an increase from the previous forecast.
The most recent analyst rating on (JP:7917) stock is a Buy with a Yen1248.00 price target. To see the full list of analyst forecasts on Fujimori Kogyo Co stock, see the JP:7917 Stock Forecast page.